Back to Journals » Breast Cancer: Targets and Therapy » Volume 16 » Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
Please verify you are not a robot.